Thus, c-KIT-targeted NIR-PIT, whose efficacy was investigated in in vivo gastrointestinal stromal tumor mouse models [166], may be utilized to treat chemorefractory non-seminomatous germ cell tumors. The gene discussed is KIT; the disease is germ cell tumor.